$ORA

STERN STANLEY sold $35K of ORA

STERN STANLEY sold 250 shares of ORMAT TECHNOLOGIES, INC. (ORA) at $138.42 on 2026-05-27.

Original reporting
SEC EDGAR · STERN STANLEY
Published May 29, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 8:52 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ORA
Neutral
high confidence
Mentioned
$ORA
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ORANeutralLow
01

Why it matters

A director open-market sale is disclosed, but there is no accompanying company-specific fundamental update in the text.

02

Market read

Traders may note insider selling, but the disclosed transaction size and lack of fundamental catalysts make it unlikely to materially change ORA’s valuation outlook.

03

What to watch

Insider sales can be non-informational, and the article provides no follow-on context such as other concurrent insider trades or changes in holdings beyond the post-sale balance.

Relevance 3/10Novelty 2/10Timing: filed 2026-05-29, transaction dated 2026-05-27

Background

The article is an SEC Form 4 insider transaction disclosure for Ormat Technologies, Inc.

Company-level read

Ticker impact

$ORANeutralHigh confidence
Context

Ormat Technologies director Stern Stanley filed a Form 4 selling 250 shares at $138.42 on 2026-05-27, totaling $34,605.

Expected impact

Likely minimal near-term impact; any effect would be sentiment-only and not a fundamental catalyst.

Evidence & confidence

The filing is a Form 4 insider transaction, not an earnings, guidance, deal, or regulatory event. The transaction value ($34,605) and director role suggest limited market-moving significance.

Market effects

No clear sector read-through from a small director sale.

None indicated.

None indicated.

Counterpoint

The absence of a 10b5-1 plan does not necessarily imply bearish intent; directors may sell for diversification or tax needs.

Key entities

  • Ormat Technologies, Inc.

    Subject of the Form 4 insider transaction disclosure (ORA).

  • Stern Stanley

    Director who sold 250 shares at $138.42 on 2026-05-27.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ORAMed

Why Ormat Technologies Stock Is Powering Down Today

Ormat Technologies (ORA) shares fell 2% on October 1, following a 10.3% drop in September. UBS downgraded the stock to neutral and lowered its price target to $100, citing reduced 2028 EBITDA guidance. Ormat expects 2028 revenue of $1.225B-$1.275B and EBITDA of $750M-$800M, down from 2025 figures of $990M and $582M, respectively.

$ORAMedAI 8/10

Why Ormat Technologies Stock Could Be a Geothermal Powerhouse

Ormat Technologies (ORA) reported Q2 revenue growth of 10.6% YoY to $258.8M, with energy-storage revenue up 195% YoY. Google (GOOG) agreed to use Ormat's geothermal energy for AI data centers. Ormat is developing enhanced geothermal systems (EGS) with Pentagon interest. The company expects $1.15B-$1.2B revenue in 2026, with a low EV/EBITDA ratio of 16.6x.